Lasa Supergenerics
Lasa Supergenerics Share Price Chart
Lasa Supergenerics last traded at ₹5.55 (2026-10-13). Over the past month the stock moved -15.8%, three months the stock moved -32.5%, year the stock moved -57.7%. Its closing range over 52 weeks is ₹5.25 – ₹11.60, with the latest close 52.2% below the high.
Closing prices up to 2026-10-13.
About Lasa Supergenerics
Incorporated in 2016, Lasa Supergenerics Ltd is in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc.[1]
Business Overview:[1] LSL is a part of Lasa group which is a veterinary API manufacturing entity. It specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary APIs with one of the largest production capabilities in India. It covers entire animal and human healthcare value chain—from discovery-to-delivery, in research, manufacturing and global marketing. Company has backward integrated its key molecules—from discovery research up to full-scale bulk production
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Lasa Supergenerics reported sales of ₹1.23 crore (-93.9%) and net profit of ₹-3.58 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 1.23 | -1.39 | -113.01 | -3.58 | -0.71 |
| Mar 2026 | -0.13 | -2.12 | – | -4.16 | -0.83 |
| Dec 2025 | 2.20 | -0.75 | -34.09 | -2.55 | -0.51 |
| Sep 2025 | 3.06 | -4.00 | -130.72 | -6.25 | -1.25 |
| Jun 2025 | 20.01 | -0.50 | -2.50 | -21.12 | -4.22 |
| Mar 2025 | 39.14 | 3.41 | 8.71 | -14.29 | -2.85 |
| Dec 2024 | 33.08 | 0.27 | 0.82 | 5.49 | 1.10 |
| Sep 2024 | 39.39 | 0.79 | 2.01 | -3.23 | -0.64 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +62.1% | +24.1% | +71.5% | -35.1% | -92.2% | -93.3% | -100.3% | -93.9% |
| Operating profit growth | -24.8% | -74.5% | – | -127.8% | -606.3% | -377.8% | -162.2% | – |
| Net profit growth | – | – | – | – | – | -146.4% | – | – |
| EPS growth | – | – | – | – | – | -146.4% | – | – |
| OPM % | 2.0% | 0.8% | 8.7% | -2.5% | -130.7% | -34.1% | – | -113.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Lasa Supergenerics reported sales of ₹25.00 crore (-82.4%) and net profit of ₹-34.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 25.00 | -7.00 | -29.00 | -34.00 | -6.80 |
| Mar 2025 | 142.00 | 6.00 | 4.00 | -15.00 | -2.95 |
| Mar 2024 | 104.00 | 2.00 | 2.00 | -22.00 | -4.34 |
| Mar 2023 | 130.00 | -6.00 | -5.00 | -39.00 | -7.71 |
| Mar 2022 | 137.00 | 16.00 | 12.00 | -5.00 | -1.31 |
| Mar 2021 | 201.00 | 47.00 | 24.00 | 23.00 | 5.60 |
| Mar 2020 | 167.00 | 30.00 | 18.00 | 4.00 | 0.89 |
| Mar 2019 | 170.00 | 11.00 | 7.00 | -12.00 | -5.26 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -30.3% | -1.8% | +20.4% | -31.8% | -5.1% | -20.0% | +36.5% | -82.4% |
| Operating profit growth | -73.2% | +172.7% | +56.7% | -66.0% | -137.5% | – | +200.0% | -216.7% |
| Net profit growth | -200.0% | – | +475.0% | -121.7% | – | – | – | – |
| EPS growth | -197.4% | – | +529.2% | -123.4% | – | – | – | – |
| OPM % | 7.0% | 18.0% | 24.0% | 12.0% | -5.0% | 2.0% | 4.0% | -29.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Lasa Supergenerics.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Lasa Supergenerics.
Frequently Asked Questions
What is the share price of Lasa Supergenerics today?
Lasa Supergenerics shares were last quoted at ₹5.55 (+4.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Lasa Supergenerics?
Lasa Supergenerics has a price-to-earnings (P/E) ratio of -1.72 and a price-to-book (P/B) ratio of 0.62. The industry P/E is 59.54.
What is the 52-week high and low of Lasa Supergenerics?
The 52-week high of Lasa Supergenerics is ₹12.46 and the 52-week low is ₹5.65.
What is the market cap of Lasa Supergenerics?
The market capitalisation of Lasa Supergenerics is about ₹28.41 crore.
How did Lasa Supergenerics perform in its latest quarterly results?
In the latest quarter (Jun 2026), Lasa Supergenerics reported sales of ₹1.23 crore (-93.9%) and net profit of ₹-3.58 crore, compared with the same quarter last year.
Is Lasa Supergenerics a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Lasa Supergenerics has a 3-year ROE of -10.00%, 3-year profit growth of 10.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Lasa Supergenerics?
Promoters hold about 53.65% of Lasa Supergenerics.
Which sector does Lasa Supergenerics belong to?
Lasa Supergenerics belongs to the Pharmaceuticals & Drugs sector.